Global Protein Engineering Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Protein Engineering Market is presumed to reach the market size of nearly USD 8.74 Billion by 2032 from USD 2.09 Billion in 2023 with a CAGR of 17.23% under the study period 2024 - 2032.

Protein engineering is a biotechnology field focused on designing, modifying, and optimizing proteins for specific applications. It involves molecular modeling, rational design, directed evolution, and recombinant DNA technology to create proteins with desired properties and functionalities. It has diverse applications in medicine, agriculture, industry, and biotechnology, including developing therapeutic proteins, enzymes, vaccines, biosensors, and biomaterials. By harnessing the principles of protein structure and function, protein engineering enables the design of novel molecules with improved stability, activity, specificity, and other desired characteristics.

MARKET DYNAMICS

Increasing demand for therapeutic proteins and biopharmaceuticals for treating various diseases, including cancer, autoimmune disorders, and infectious diseases, drives the need for innovative protein engineering technologies to optimize protein function, stability, and pharmacokinetics. Additionally, advancements in protein engineering techniques, such as rational design, directed evolution, and computational modeling, enable the development of novel protein-based therapeutics with enhanced efficacy, specificity, and safety profiles. Furthermore, the growing investment in biotechnology research and development by pharmaceutical companies, academic institutions, and government agencies is fueling innovation and driving the commercialization of protein engineering technologies.

Moreover, the expanding applications of protein engineering beyond therapeutics, such as enzyme engineering for industrial biocatalysis, protein design for biomaterials and drug delivery systems, and protein optimization for agricultural biotechnology, are creating new market opportunities and driving growth. The increasing adoption of protein engineering technologies in personalized medicine, diagnostics, and regenerative medicine drives market expansion. Furthermore, strategic collaborations and partnerships among companies, biopharmaceutical firms, and research institutions are fostering innovation and accelerating the development and commercialization of protein-based products. However, concerns regarding privacy and data security in medical devices may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of protein engineering. The growth and trends of protein engineering industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the protein engineering market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Reagents
Software & Services

By Technology

Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others

By Protein Type

Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others

By End-Use

Academic Research Institutes
Contract Research Organizations (Cros)
Pharmaceutical & Biotechnology Companies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Protein Engineering market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Protein Engineering market include Agilent Technologies, Bruker Corp., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corp., Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Genscript Biotech Corp, Amgen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112114269

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROTEIN ENGINEERING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Protein Type
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Instruments Historic and Forecast Sales By Regions
5.5. Reagents Historic and Forecast Sales By Regions
5.6. Software & Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data
6.3. Analysis By Technology
6.4. Rational Protein Design Historic and Forecast Sales By Regions
6.5. Directed Evolution Historic and Forecast Sales By Regions
6.6. Hybrid Approach Historic and Forecast Sales By Regions
6.7. De Novo Protein Design Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PROTEIN TYPE

7.1. Overview By Protein Type
7.2. Historical and Forecast Data
7.3. Analysis By Protein Type
7.4. Insulin Historic and Forecast Sales By Regions
7.5. Monoclonal Antibodies Historic and Forecast Sales By Regions
7.6. Vaccines Historic and Forecast Sales By Regions
7.7. Growth Factors Historic and Forecast Sales By Regions
7.8. Colony Stimulating Factors Historic and Forecast Sales By Regions
7.9. Coagulation Factors Historic and Forecast Sales By Regions
7.10. Interferon Historic and Forecast Sales By Regions
7.11. Others Historic and Forecast Sales By Regions

8. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data
8.3. Analysis By End-use
8.4. Academic Research Institutes Historic and Forecast Sales By Regions
8.5. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
8.6. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions

9. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PROTEIN ENGINEERING COMPANIES

10.1. Protein Engineering Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PROTEIN ENGINEERING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Agilent Technologies
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Bruker Corp.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. PerkinElmer Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Waters Corp.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Bio-Rad Laboratories
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Merck KGaA
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Danaher Corp.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Genscript Biotech Corp
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Amgen Inc.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies